Foliaki Sunia, Best Diana, Akau'ola Siale, Cheng Soo, Borman Barry, Pearce Neil
Centre for Public Health Research, Massey University, Wellington, New Zealand.
Pac Health Dialog. 2011 Mar;17(1):21-32.
We have established and/or upgraded cancer registries in four Pacific countries, a region where few cancer registries exist. We report age-standardised cancer incidence in Tonga (2000-2005), Fiji (2002-2005), Cook Islands (2000-2005) and Niue (2000-2005), and in Pacific people in New Zealand (2000-2005).
In each country we identified incident cancer cases by reviewing hospital discharge, death registration, cancer registration records, and pathology reports. The primary site and morphology data were coded using ICD-0, and age-standardised incidence rates were calculated.
Age-standardised cancer incidence rates for Pacific people in New Zealand (315 per 100,000 person-years in females, 379 in males) were similar to those for New Zealand overall (322 in females, 404 in males); incidence rates were lower in the Pacific, with rates of 195 and 151 per 100,000 person-years for females and males respectively in Tonga, 231 and 126 in Fiji, 165 and 142 in the Cook Islands, and 228 and 131 in Niue. However, some specific cancers were elevated in the Pacific including cervical cancer (16 per 100,000 in Tonga, 51 in Fiji, 17 in Cook Islands, and 26 in Niue compared with 10 in Pacific people in New Zealand, and 8 in New Zealand overall), liver cancer (rates of 8, 5, 19, 0, 7, and 2 respectively) and uterine cancer (rates of 24, 18, 47, 19 and 12 respectively).
Cancer incidence in the Pacific is lower than for Pacific people living in New Zealand. Environmental rather than genetic factors are most likely to explain these patterns, and cancer incidence in the Pacific is likely to increase to rates similar to those in New Zealand as the region becomes more 'westernised' The high rates of cervical cancer and liver cancer in the Pacific indicate an important role of
我们在四个太平洋国家建立和/或升级了癌症登记处,该地区现存的癌症登记处很少。我们报告了汤加(2000 - 2005年)、斐济(2002 - 2005年)、库克群岛(2000 - 2005年)和纽埃(2000 - 2005年)以及新西兰太平洋人群(2000 - 2005年)的年龄标准化癌症发病率。
在每个国家,我们通过查阅医院出院记录、死亡登记、癌症登记记录和病理报告来确定新发癌症病例。主要部位和形态学数据使用ICD - 0进行编码,并计算年龄标准化发病率。
新西兰太平洋人群的年龄标准化癌症发病率(女性为每10万人年315例,男性为379例)与新西兰总体发病率(女性为322例,男性为404例)相似;太平洋地区发病率较低,汤加女性和男性的发病率分别为每10万人年195例和151例,斐济为231例和126例,库克群岛为165例和142例,纽埃为228例和131例。然而,太平洋地区一些特定癌症的发病率有所升高,包括宫颈癌(汤加每10万人年16例,斐济为51例,库克群岛为17例,纽埃为26例,相比之下,新西兰太平洋人群为10例,新西兰总体为8例)、肝癌(发病率分别为8、5、19、0、7和2)和子宫癌(发病率分别为24、18、47、19和12)。
太平洋地区的癌症发病率低于居住在新西兰的太平洋人群。环境因素而非遗传因素最有可能解释这些模式,随着该地区变得更加“西方化”,太平洋地区的癌症发病率可能会上升至与新西兰相似的水平。太平洋地区宫颈癌和肝癌的高发病率表明……的重要作用